|
ALNY
|
Alnylam Pharmaceuticals, Inc.
|
3.34%
|
US
|
NASDAQ
|
|
BIO
|
Bio-Rad Laboratories, Inc.
|
3.21%
|
US
|
NYSE
|
|
SGEN
|
Seattle Genetics, Inc.
|
3.12%
|
US
|
NASDAQ
|
|
NVCR
|
NovoCure Limited
|
2.98%
|
US
|
NASDAQ
|
|
SRPT
|
Sarepta Therapeutics, Inc.
|
2.78%
|
US
|
NASDAQ
|
|
EXAS
|
Exact Sciences Corporation
|
2.19%
|
US
|
NASDAQ
|
|
INSP
|
Inspire Medical Systems, Inc.
|
1.86%
|
US
|
NYSE
|
|
KRTX
|
Karuna Therapeutics, Inc.
|
1.74%
|
US
|
NASDAQ
|
|
ELAN
|
Elanco Animal Health Incorporated
|
1.58%
|
US
|
NYSE
|
|
IONS
|
Ionis Pharmaceuticals, Inc.
|
1.51%
|
US
|
NASDAQ
|
|
MDGL
|
Madrigal Pharmaceuticals, Inc.
|
1.34%
|
US
|
NASDAQ
|
|
APLS
|
Apellis Pharmaceuticals, Inc.
|
1.34%
|
US
|
NASDAQ
|
|
ITCI
|
Intra-Cellular Therapies Inc.
|
1.30%
|
US
|
NASDAQ
|
|
PRGO
|
Perrigo Company
|
1.28%
|
US
|
NYSE
|
|
CERE
|
Cerevel Therapeutics Holdings, Inc.
|
1.27%
|
US
|
NASDAQ
|
|
ALKS
|
Alkermes plc
|
1.18%
|
US
|
NASDAQ
|
|
CYTK
|
Cytokinetics, Incorporated
|
1.09%
|
US
|
NASDAQ
|
|
ARWR
|
Arrowhead Research Corporation
|
1.04%
|
US
|
NASDAQ
|
|
DNLI
|
Denali Therapeutics Inc.
|
1.03%
|
US
|
NASDAQ
|
|
TXG
|
10x Genomics, Inc.
|
0.97%
|
US
|
NASDAQ
|